title: Is there a best strategy for drug discovery?--SMR Meeting. 13 March 2003, London, UK.
abstract: This gathering of members from academia and industry allowed the sharing of ideas and techniques or the acceleration of drug discovery, and it was clear that there is a need for a more streamlined approach to discovery and development. Clearly, new technologies will aid in the discovery process, but the abilities of the human brain to analyze and interpret data should not be overlooked, as many discoveries have been made by chance or as the result of a hunch, and it would be a shame if the advent of artificial intelligence quashed that inquisitive aspect of drug discovery.
authors.affiliation: Thompson Current Drugs, Middlesex House, London, UK. anna.lunec@current-drugs.com
authors.forename: Anna
authors.initials: A
authors.lastname: Lunec
mesh_terms: D000818:Animals; D015195:Drug Design; D006801:Humans; D010597:Pharmacogenetics / Q000379:methods / Q000639:trends; D012955:Societies, Medical / Q000639:trends*; D013678:Technology, Pharmaceutical / Q000379:methods* / Q000639:trends*